Menu
Currency
GWAS Study

Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study.

Duckworth A, Gibbons MA, Allen RJ et al.

33197388 PubMed ID
GWAS Study Type
451025 Participants
84 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DA
Duckworth A
GM
Gibbons MA
AR
Allen RJ
AH
Almond H
BR
Beaumont RN
WA
Wood AR
LK
Lunnon K
LM
Lindsay MA
WL
Wain LV
TJ
Tyrrell J
SC
Scotton CJ
Chapter II

Abstract

Summary of the research findings

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease accounting for 1% of UK deaths. In the familial form of pulmonary fibrosis, causal genes have been identified in about 30% of cases, and a majority of these causal genes are associated with telomere maintenance. Prematurely shortened leukocyte telomere length is associated with IPF and chronic obstructive pulmonary disease (COPD), a disease with similar demographics and shared risk factors. Using mendelian randomisation, we investigated evidence supporting a causal role for short telomeres in IPF and COPD.

1,369 European ancestry cases, 435,866 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

451025
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.